PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.41%
Revenue growth under 50% of MRVL's 40.11%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
11.96%
Gross profit growth under 50% of MRVL's 41.63%. Michael Burry would be concerned about a severe competitive disadvantage.
-19.51%
Negative EBIT growth while MRVL is at 55.44%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-19.51%
Negative operating income growth while MRVL is at 55.44%. Joel Greenblatt would press for urgent turnaround measures.
-16.72%
Negative net income growth while MRVL stands at 56.19%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
-18.75%
Negative diluted EPS growth while MRVL is at 74.44%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-14.34%
Share reduction while MRVL is at 69.81%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
2.39%
Diluted share reduction more than 1.5x MRVL's 69.81%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
129.66%
OCF growth under 50% of MRVL's 346.70%. Michael Burry might suspect questionable revenue recognition or rising costs.
392.13%
FCF growth above 1.5x MRVL's 254.51%. David Dodd would verify if the firm’s strategic investments yield superior returns.
186.63%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
186.63%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
186.63%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
786.36%
10Y OCF/share CAGR above 1.5x MRVL's 20.30%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
786.36%
5Y OCF/share CAGR above 1.5x MRVL's 20.30%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
786.36%
3Y OCF/share CAGR above 1.5x MRVL's 20.30%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
246.81%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
246.81%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
246.81%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
410.21%
Below 50% of MRVL's 6767.83%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
410.21%
Below 50% of MRVL's 6767.83%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
410.21%
Below 50% of MRVL's 6767.83%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.49%
Firm’s AR is declining while MRVL shows 1.73%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-3.49%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
6.43%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
33.31%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-0.08%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
18.01%
R&D dropping or stable vs. MRVL's 70.25%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
11.29%
SG&A declining or stable vs. MRVL's 52.56%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.